Infant circulating MicroRNAs as biomarkers of effect in fetal alcohol spectrum disorders

Abstract Prenatal alcohol exposure (PAE) can result in cognitive and behavioral disabilities and growth deficits. Because alcohol-related neurobehavioral deficits may occur in the absence of overt dysmorphic features or growth deficits, there is a need to identify biomarkers of PAE that can predict...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amanda H. Mahnke, Georgios D. Sideridis, Nihal A. Salem, Alexander M. Tseng, R. Colin Carter, Neil C. Dodge, Aniruddha B. Rathod, Christopher D. Molteno, Ernesta M. Meintjes, Sandra W. Jacobson, Rajesh C. Miranda, Joseph L. Jacobson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d5ca958dd8ca40a9a1ee3267343b567a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d5ca958dd8ca40a9a1ee3267343b567a
record_format dspace
spelling oai:doaj.org-article:d5ca958dd8ca40a9a1ee3267343b567a2021-12-02T14:01:38ZInfant circulating MicroRNAs as biomarkers of effect in fetal alcohol spectrum disorders10.1038/s41598-020-80734-y2045-2322https://doaj.org/article/d5ca958dd8ca40a9a1ee3267343b567a2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-80734-yhttps://doaj.org/toc/2045-2322Abstract Prenatal alcohol exposure (PAE) can result in cognitive and behavioral disabilities and growth deficits. Because alcohol-related neurobehavioral deficits may occur in the absence of overt dysmorphic features or growth deficits, there is a need to identify biomarkers of PAE that can predict neurobehavioral impairment. In this study, we assessed infant plasma extracellular, circulating miRNAs ( ex miRNAs) obtained from a heavily exposed Cape Town cohort to determine whether these can be used to predict PAE-related growth restriction and cognitive impairment. PAE, controlling for smoking as a covariate, altered 27% of expressed ex miRNAs with clinically-relevant effect sizes (Cohen’s d ≥ 0.4). Moreover, at 2 weeks, PAE increased correlated expression of ex miRNAs across chromosomes, suggesting potential co-regulation. In confirmatory factor analysis, the variance in expression for PAE-altered ex miRNAs at 2 weeks and 6.5 months was best described by three-factor models. Pathway analysis found that factors at 2 weeks were associated with (F1) cell maturation, cell cycle inhibition, and somatic growth, (F2) cell survival, apoptosis, cardiac development, and metabolism, and (F3) cell proliferation, skeletal development, hematopoiesis, and inflammation, and at 6.5 months with (F1) neurodevelopment, neural crest/mesoderm-derivative development and growth, (F2) immune system and inflammation, and (F3) somatic growth and cardiovascular development. Factors F3 at 2 weeks and F2 at 6.5 months partially mediated PAE-induced growth deficits, and factor F3 at 2 weeks partially mediated effects of PAE on infant recognition memory at 6.5 months. These findings indicate that infant ex miRNAs can help identify infants who will exhibit PAE-related deficits in growth and cognition.Amanda H. MahnkeGeorgios D. SideridisNihal A. SalemAlexander M. TsengR. Colin CarterNeil C. DodgeAniruddha B. RathodChristopher D. MoltenoErnesta M. MeintjesSandra W. JacobsonRajesh C. MirandaJoseph L. JacobsonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-23 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Amanda H. Mahnke
Georgios D. Sideridis
Nihal A. Salem
Alexander M. Tseng
R. Colin Carter
Neil C. Dodge
Aniruddha B. Rathod
Christopher D. Molteno
Ernesta M. Meintjes
Sandra W. Jacobson
Rajesh C. Miranda
Joseph L. Jacobson
Infant circulating MicroRNAs as biomarkers of effect in fetal alcohol spectrum disorders
description Abstract Prenatal alcohol exposure (PAE) can result in cognitive and behavioral disabilities and growth deficits. Because alcohol-related neurobehavioral deficits may occur in the absence of overt dysmorphic features or growth deficits, there is a need to identify biomarkers of PAE that can predict neurobehavioral impairment. In this study, we assessed infant plasma extracellular, circulating miRNAs ( ex miRNAs) obtained from a heavily exposed Cape Town cohort to determine whether these can be used to predict PAE-related growth restriction and cognitive impairment. PAE, controlling for smoking as a covariate, altered 27% of expressed ex miRNAs with clinically-relevant effect sizes (Cohen’s d ≥ 0.4). Moreover, at 2 weeks, PAE increased correlated expression of ex miRNAs across chromosomes, suggesting potential co-regulation. In confirmatory factor analysis, the variance in expression for PAE-altered ex miRNAs at 2 weeks and 6.5 months was best described by three-factor models. Pathway analysis found that factors at 2 weeks were associated with (F1) cell maturation, cell cycle inhibition, and somatic growth, (F2) cell survival, apoptosis, cardiac development, and metabolism, and (F3) cell proliferation, skeletal development, hematopoiesis, and inflammation, and at 6.5 months with (F1) neurodevelopment, neural crest/mesoderm-derivative development and growth, (F2) immune system and inflammation, and (F3) somatic growth and cardiovascular development. Factors F3 at 2 weeks and F2 at 6.5 months partially mediated PAE-induced growth deficits, and factor F3 at 2 weeks partially mediated effects of PAE on infant recognition memory at 6.5 months. These findings indicate that infant ex miRNAs can help identify infants who will exhibit PAE-related deficits in growth and cognition.
format article
author Amanda H. Mahnke
Georgios D. Sideridis
Nihal A. Salem
Alexander M. Tseng
R. Colin Carter
Neil C. Dodge
Aniruddha B. Rathod
Christopher D. Molteno
Ernesta M. Meintjes
Sandra W. Jacobson
Rajesh C. Miranda
Joseph L. Jacobson
author_facet Amanda H. Mahnke
Georgios D. Sideridis
Nihal A. Salem
Alexander M. Tseng
R. Colin Carter
Neil C. Dodge
Aniruddha B. Rathod
Christopher D. Molteno
Ernesta M. Meintjes
Sandra W. Jacobson
Rajesh C. Miranda
Joseph L. Jacobson
author_sort Amanda H. Mahnke
title Infant circulating MicroRNAs as biomarkers of effect in fetal alcohol spectrum disorders
title_short Infant circulating MicroRNAs as biomarkers of effect in fetal alcohol spectrum disorders
title_full Infant circulating MicroRNAs as biomarkers of effect in fetal alcohol spectrum disorders
title_fullStr Infant circulating MicroRNAs as biomarkers of effect in fetal alcohol spectrum disorders
title_full_unstemmed Infant circulating MicroRNAs as biomarkers of effect in fetal alcohol spectrum disorders
title_sort infant circulating micrornas as biomarkers of effect in fetal alcohol spectrum disorders
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d5ca958dd8ca40a9a1ee3267343b567a
work_keys_str_mv AT amandahmahnke infantcirculatingmicrornasasbiomarkersofeffectinfetalalcoholspectrumdisorders
AT georgiosdsideridis infantcirculatingmicrornasasbiomarkersofeffectinfetalalcoholspectrumdisorders
AT nihalasalem infantcirculatingmicrornasasbiomarkersofeffectinfetalalcoholspectrumdisorders
AT alexandermtseng infantcirculatingmicrornasasbiomarkersofeffectinfetalalcoholspectrumdisorders
AT rcolincarter infantcirculatingmicrornasasbiomarkersofeffectinfetalalcoholspectrumdisorders
AT neilcdodge infantcirculatingmicrornasasbiomarkersofeffectinfetalalcoholspectrumdisorders
AT aniruddhabrathod infantcirculatingmicrornasasbiomarkersofeffectinfetalalcoholspectrumdisorders
AT christopherdmolteno infantcirculatingmicrornasasbiomarkersofeffectinfetalalcoholspectrumdisorders
AT ernestammeintjes infantcirculatingmicrornasasbiomarkersofeffectinfetalalcoholspectrumdisorders
AT sandrawjacobson infantcirculatingmicrornasasbiomarkersofeffectinfetalalcoholspectrumdisorders
AT rajeshcmiranda infantcirculatingmicrornasasbiomarkersofeffectinfetalalcoholspectrumdisorders
AT josephljacobson infantcirculatingmicrornasasbiomarkersofeffectinfetalalcoholspectrumdisorders
_version_ 1718392111976415232